Press "Enter" to skip to content

New patent for Amarin Pharms drug VASCEPA

3
Copyright © DrugPatentWatch. Originally published at New patent for Amarin Pharms drug VASCEPA

Annual Drug Patent Expirations for VASCEPA
Annual Drug Patent Expirations for VASCEPA

Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are fifty-six patents protecting this drug and three Paragraph IV challenges.

VASCEPA drug price trends.

Drug patent litigation for VASCEPA.

This drug has two hundred and fifty-two patent family members in fifty countries.

The generic ingredient in VASCEPA is icosapent ethyl. Two suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Amarin Pharms drug VASCEPA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!